Diabetes

This hub delivers an in-depth, evidence-based exploration of diabetes mellitus, uniting authoritative articles on disease mechanisms, diagnosis, management, and prevention. Covering both type 1 and type 2 diabetes, as well as rare and secondary forms, this collection provides readers with comprehensive information on risk factors, clinical presentation, complications, and the latest advances in research and technology. Topics include the impact of nutrition and lifestyle, pharmacological and non-pharmacological therapies, monitoring strategies, acute and chronic complications, and innovative developments such as artificial pancreas systems and digital health tools. These resources also examine the psychosocial aspects of living with diabetes and offer practical guidance for both patients and healthcare professionals. Whether you seek foundational knowledge or current developments in diabetes care, this hub serves as a trusted, up-to-date reference.

Foods That Help Lower Blood Sugar Naturally

Low-glycemic foods, dietary fiber, resistant starch, and balanced eating patterns control blood sugar levels to support long-term metabolic health.

Is a Plant-Based Diet Good for Type 2 Diabetes?

Diabetic Neuropathy Diagnosis

Red Blood Cell Morphology Changes in Diabetes

Nonketotic Hyperosmolar Coma

How does Gestational Diabetes Affect the Baby?

Effects of Hyperglycemia on the Vascular System

Encapsulating Islet Cells for the Treatment of Diabetes

Diabetes and Skin Problems

Diabetes and Mucormycosis

What Causes Diabetes?

Diabetic Retinopathy Treatments

See more featured articles »

Diabetic Neuropathy Pathogenesis

Diabetes in Men versus Women

Are Low Carbohydrate Diets Good for Type 2 Diabetes?

Diabetic Mastopathy: Complication of Diabetes Mellitus

Alcohol and Diabetes

Diabetic Retinopathy Symptoms

Diabetic Coma Severe Hypoglycemia

What is Diabetic Retinopathy?

Diabetes Pathophysiology

Supplements for Diabetes

Harnessing the Power of AI: Predicting Diabetes Onset Before It Strikes

The Risks of Prediabetes

Diabetes Types

What is Diabetes?

Can I reverse my prediabetes naturally

What Causes Diabetic Nephropathy (Kidney Disease)?

Diabetes in Men

Navigating Insulin Pumps: Technology, Benefits, and What’s Next

What are Nightmares and Why Do They Occur?

Diabetic Coma Treatments

Epigenetic Mechanisms in Type 2 Diabetes

The Impact of Glucagon on Diabetes Management

Diabetic Nephropathy Treatment

Diabetes Diagnosis

Semaglutide and Type 2 Diabetes: Efficacy, Safety, and Outcomes

Adiponectin and Diabetes

Causes of Foot Pain

Diabetic Retinopathy Risk Factors

What is Diabetic Nephropathy?

Okra and Diabetes: What Research Says About Its Blood Sugar Control Effects

Diabetes and Vision

Pins and Needles and Diabetes

Genetic Testing for Diabetes

Walking After Meals: Small Habit, Big Metabolic Gains

Animals That Can Detect Hypoglycemia

What is Diabetic Neuropathy?

What is Diabetic Hypoglycemia?

COVID-19 and Diabetes

What's Next for Semaglutide? Beyond Diabetes and Weight Loss

Treatment and Prognosis for Diabetic Mastopathy

Bionic Advancements: The Next Generation of Insulin Delivery Devices

Low Sugar Foods for Diabetes

Does the 'Stomach Flu' Vaccine Prevent Type I Diabetes?

What is HbA1C Testing?

Diabetes Screening

Hypoglycemic Unawareness

Diabetes Symptoms

Diabetes and Periodontitis

Does the Keto Diet Increase the Risk of Diabetes?

What is a Diabetic Coma?

Diabetic Ketoacidosis Causes

How Baking Soda Affects People with Type 2 Diabetes

What is Diabetic Ketoacidosis?

Vitamin D and Type 2 Diabetes

How Does Semaglutide Work to Lose Weight?

Diabetic Neuropathy Treatments

Diabetic Hypoglycemia Treatments

Diabetic Neuropathy Symptoms

Risks to Infants of Diabetic Mothers

What is HbA1c?

Diabetes Management

Advanced Diabetic Ketoacidosis

Diabetic Hypoglycemia Etiology

Diabetic Retinopathy Diagnosis

Diabetic Foot Problems

Understanding MODY 5: A Rare Genetic Form of Diabetes

Artificial Pancreas Systems: The Future of Diabetes Management?

Diabetes and Pregnancy

Diabetic Nephropathy Symptoms

Diabetic Emergencies: What to Do

Diabetes Complications

Diabetic Mastopathy Diagnosis

Research into a Cure for Diabetes

Diabetes and Wound Healing

The Future of Diabetes Treatment

Diabetes and Sleep

Diabetes Risk Factors

Cause of Diabetic Coma

History of Diabetes

Latest Diabetes News and Research

Mauritius becomes first country to reverse type 2 diabetes epidemic

New research to be presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) and published in The Lancet Diabetes & Endocrinology shows that the small island nation of Mauritius is the first country in the world to prove it is reversing the type 2 diabetes epidemic using the objective gold standard testing method of the 2-hour oral glucose tolerance test (2 hour OGTT).

1 Oct 2026

Trevogrumab cuts semaglutide-induced lean mass loss by half, study shows

New research to be presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) and in press with The Lancet shows that using the trevogrumab to inhibit myostatin, a protein that negatively regulates muscle mass, can reduce lean mass loss during treatment with semaglutide by 50% compared with semaglutide and placebo.

1 Oct 2026

Do you really need to fast before a blood test? It depends on the test

The impact of fasting on blood test results is analyte-specific, with most routine tests showing minimal differences, suggesting a need for flexible guidelines.

1 Oct 2026

Real-world data reveals higher reported GLP-1 side effects in female patients

The second of a Series of papers presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) and published in The Lancet Obstetrics, Gynaecology & Women's Health discusses the wide-ranging issues relating to use of GLP-1 RA drug use in women.

1 Oct 2026

GLP-1 receptor agonist exposure shows no link to major adverse pregnancy outcomes

New research to be presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) and published in The Lancet Obstetrics, Gynaecology & Women's Health shows that, following a review and meta-analysis of available studies, use of glucagon-like peptide-1 receptor agonists (GLP-1 RA) drugs for diabetes and weight management in women living with diabetes is not associated with adverse pregnancy outcomes in most cases.

1 Oct 2026

Early-onset type 2 diabetes trial demonstrates significant 24-week fat loss

New research to be presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) and published in The Lancet Regional Health Americas journal shows that in people who have developed early onset type 2 diabetes (EOT2D) (aged under 45 years), around half these T2D cases can be reversed with a low-energy diet combined with a structured exercise program.

1 Oct 2026

Fluorescent sensors could help researchers see diabetes in action

Researchers from the University of Bath have developed fluorescent molecular probes that can detect changes in glucose levels inside living animals, giving scientists new ways of visualizing sugar uptake, studying diabetes, cancer and other metabolic diseases in whole organisms in real time.

1 Oct 2026

Study examines the real-world use of GLP-1 RA drugs in children and young people

New research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) has examined the real-world use of GLP-1 receptor agonist (GLP-1 RA) drugs in children and young people in Germany, Austria and Luxembourg.

30 Sep 2026

Overall dietary patterns matter more for heart health than nutrients

A healthy, balanced dietary pattern, rather than one focused on individual nutrients or foods is key to maintaining heart health, according to a Scientific Statement issued by the American College of Cardiology and published in JACC, its flagship journal.

30 Sep 2026

Novo Nordisk Foundation funds genomic research into metabolic diseases

The Novo Nordisk Foundation has committed $53 million to renew and expand the Novo Nordisk Foundation Center for Genomic Mechanisms of Disease at the Broad Institute, led by managing director Kasper Lage.

30 Sep 2026

Petrelintide produces double-digit weight loss with fewer side effects

New research to be presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) and published in The Lancet Diabetes & Endocrinology shows that weekly injections with the new amylin-based obesity drug petrelintide can enable those treated to lose more than 10% of their body weight – generally lower than existing incretin-based (GLP-1 RA) drugs, but also with far fewer side effects.

29 Sep 2026

Researchers found a curious mitochondrial pattern in people who moved more

Researchers found that greater self-reported activity, walking, and accelerometer-measured light activity were associated with higher mitochondrial DNA copy number in 256 healthy middle-aged adults. The cross-sectional findings cannot establish causation, and the very low amount of vigorous activity means they do not show that light movement is more beneficial than higher-intensity exercise.

29 Sep 2026

$5.7 million NIH grant supports research on why lean people develop insulin resistance

A Wayne State University research team was awarded a $5.7 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health focused on discovering the biological mechanisms that may help explain why some lean people develop insulin resistance while some people with obesity remain sensitive to insulin.

29 Sep 2026

First EU Screening Week urges citizens to know their numbers

At a dedicated press conference at the EASD Annual Meeting in Milan, organized by the European Diabetes Forum (EUDF), three leading European cardiometabolic scientific associations - the European Society of Cardiology (ESC), the European Association for the Study of Diabetes (EASD) and the European Association for the Study of Obesity (EASO) - joined European Commissioner for Health and Animal Welfare Olivér Várhelyi to welcome the launch of the first-ever EU Screening Week.

29 Sep 2026

Targeting specific nuclear receptor could help preserve aging muscle function

Scientists in the Gerhart-Hines Group pinpoint a molecular cause of muscle aging, and a possible fix. By investigating how muscles adapt to age and disease-related decline, the scientists discovered the involvement of a druggable nuclear receptor, ERRγ, that could be targeted to preserve muscle function.

29 Sep 2026

Greater variation in blood pressure associated with higher risk of death and strokes

Greater variation in blood pressure between research visits was associated with a higher risk of death in a study of more than 57,000 UK Biobank participants.

29 Sep 2026

Canadian study links neighborhood poverty levels to type 2 diabetes risk

The area in which someone lives strongly influences their risk of developing type 2 diabetes, new research from Canada being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) suggests.

29 Sep 2026

Short voice recordings could screen patients for type 2 diabetes

Signs of type 2 diabetes can be detected in just a few seconds from the way someone talks, new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) shows.

29 Sep 2026

New registry data shows semaglutide does not cause pancreatic cancer

New research to be presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) shows no link between semaglutide use and pancreatic cancer using nationwide registry data from Denmark, Sweden and Norway.

29 Sep 2026

Exercise may reshape your gut microbiome to support recovery

Research reveals how exercise alters gut microbes, influencing recovery and proposing 'intestinal rehabilitation' for those with limited exercise capacity.

29 Sep 2026